249 related articles for article (PubMed ID: 23045525)
1. Src homology 2 domain-containing phosphatase 2 (Shp2) is a component of the A-kinase-anchoring protein (AKAP)-Lbc complex and is inhibited by protein kinase A (PKA) under pathological hypertrophic conditions in the heart.
Burmeister BT; Taglieri DM; Wang L; Carnegie GK
J Biol Chem; 2012 Nov; 287(48):40535-46. PubMed ID: 23045525
[TBL] [Abstract][Full Text] [Related]
2. Protein Kinase A (PKA) Phosphorylation of Shp2 Protein Inhibits Its Phosphatase Activity and Modulates Ligand Specificity.
Burmeister BT; Wang L; Gold MG; Skidgel RA; O'Bryan JP; Carnegie GK
J Biol Chem; 2015 May; 290(19):12058-67. PubMed ID: 25802336
[TBL] [Abstract][Full Text] [Related]
3. The C-terminus of the long AKAP13 isoform (AKAP-Lbc) is critical for development of compensatory cardiac hypertrophy.
Taglieri DM; Johnson KR; Burmeister BT; Monasky MM; Spindler MJ; DeSantiago J; Banach K; Conklin BR; Carnegie GK
J Mol Cell Cardiol; 2014 Jan; 66():27-40. PubMed ID: 24161911
[TBL] [Abstract][Full Text] [Related]
4. Anchoring of both PKA and 14-3-3 inhibits the Rho-GEF activity of the AKAP-Lbc signaling complex.
Diviani D; Abuin L; Cotecchia S; Pansier L
EMBO J; 2004 Jul; 23(14):2811-20. PubMed ID: 15229649
[TBL] [Abstract][Full Text] [Related]
5. A-kinase anchoring protein Lbc coordinates a p38 activating signaling complex controlling compensatory cardiac hypertrophy.
Pérez López I; Cariolato L; Maric D; Gillet L; Abriel H; Diviani D
Mol Cell Biol; 2013 Aug; 33(15):2903-17. PubMed ID: 23716597
[TBL] [Abstract][Full Text] [Related]
6. AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway.
Carnegie GK; Soughayer J; Smith FD; Pedroja BS; Zhang F; Diviani D; Bristow MR; Kunkel MT; Newton AC; Langeberg LK; Scott JD
Mol Cell; 2008 Oct; 32(2):169-79. PubMed ID: 18951085
[TBL] [Abstract][Full Text] [Related]
7. The A-kinase-anchoring protein AKAP-Lbc facilitates cardioprotective PKA phosphorylation of Hsp20 on Ser(16).
Edwards HV; Scott JD; Baillie GS
Biochem J; 2012 Sep; 446(3):437-43. PubMed ID: 22731613
[TBL] [Abstract][Full Text] [Related]
8. UCR1C is a novel activator of phosphodiesterase 4 (PDE4) long isoforms and attenuates cardiomyocyte hypertrophy.
Wang L; Burmeister BT; Johnson KR; Baillie GS; Karginov AV; Skidgel RA; O'Bryan JP; Carnegie GK
Cell Signal; 2015 May; 27(5):908-22. PubMed ID: 25683917
[TBL] [Abstract][Full Text] [Related]
9. The ubiquitin-like protein LC3 regulates the Rho-GEF activity of AKAP-Lbc.
Baisamy L; Cavin S; Jurisch N; Diviani D
J Biol Chem; 2009 Oct; 284(41):28232-28242. PubMed ID: 19696020
[TBL] [Abstract][Full Text] [Related]
10. A-kinase anchoring protein-Lbc promotes pro-fibrotic signaling in cardiac fibroblasts.
Cavin S; Maric D; Diviani D
Biochim Biophys Acta; 2014 Feb; 1843(2):335-45. PubMed ID: 24269843
[TBL] [Abstract][Full Text] [Related]
11. The in silico identification of small molecules for protein-protein interaction inhibition in AKAP-Lbc-RhoA signaling complex.
Khan A; Munir M; Aiman S; Wadood A; Khan AU
Comput Biol Chem; 2017 Apr; 67():84-91. PubMed ID: 28063348
[TBL] [Abstract][Full Text] [Related]
12. A-kinase anchoring protein (AKAP)-Lbc anchors a PKN-based signaling complex involved in α1-adrenergic receptor-induced p38 activation.
Cariolato L; Cavin S; Diviani D
J Biol Chem; 2011 Mar; 286(10):7925-7937. PubMed ID: 21224381
[TBL] [Abstract][Full Text] [Related]
13. AKAP-Lbc mediates protection against doxorubicin-induced cardiomyocyte toxicity.
Caso S; Maric D; Arambasic M; Cotecchia S; Diviani D
Biochim Biophys Acta Mol Cell Res; 2017 Dec; 1864(12):2336-2346. PubMed ID: 28923249
[TBL] [Abstract][Full Text] [Related]
14. Shp2 negatively regulates growth in cardiomyocytes by controlling focal adhesion kinase/Src and mTOR pathways.
Marin TM; Clemente CF; Santos AM; Picardi PK; Pascoal VD; Lopes-Cendes I; Saad MJ; Franchini KG
Circ Res; 2008 Oct; 103(8):813-24. PubMed ID: 18757826
[TBL] [Abstract][Full Text] [Related]
15. The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates alpha1 adrenergic receptor-induced cardiomyocyte hypertrophy.
Appert-Collin A; Cotecchia S; Nenniger-Tosato M; Pedrazzini T; Diviani D
Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10140-5. PubMed ID: 17537920
[TBL] [Abstract][Full Text] [Related]
16. Leucine zipper-mediated homo-oligomerization regulates the Rho-GEF activity of AKAP-Lbc.
Baisamy L; Jurisch N; Diviani D
J Biol Chem; 2005 Apr; 280(15):15405-12. PubMed ID: 15691829
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase A and phosphodiesterase-4D3 binding to coding polymorphisms of cardiac muscle anchoring protein (mAKAP).
Rababa'h A; Craft JW; Wijaya CS; Atrooz F; Fan Q; Singh S; Guillory AN; Katsonis P; Lichtarge O; McConnell BK
J Mol Biol; 2013 Sep; 425(18):3277-88. PubMed ID: 23806656
[TBL] [Abstract][Full Text] [Related]
18. PKA catalytic subunit compartmentation regulates contractile and hypertrophic responses to β-adrenergic signaling.
Yang JH; Polanowska-Grabowska RK; Smith JS; Shields CW; Saucerman JJ
J Mol Cell Cardiol; 2014 Jan; 66():83-93. PubMed ID: 24225179
[TBL] [Abstract][Full Text] [Related]
19. A-kinase-anchoring protein-Lbc anchors IκB kinase β to support interleukin-6-mediated cardiomyocyte hypertrophy.
del Vescovo CD; Cotecchia S; Diviani D
Mol Cell Biol; 2013 Jan; 33(1):14-27. PubMed ID: 23090968
[TBL] [Abstract][Full Text] [Related]
20. Small molecule AKAP-protein kinase A (PKA) interaction disruptors that activate PKA interfere with compartmentalized cAMP signaling in cardiac myocytes.
Christian F; Szaszák M; Friedl S; Drewianka S; Lorenz D; Goncalves A; Furkert J; Vargas C; Schmieder P; Götz F; Zühlke K; Moutty M; Göttert H; Joshi M; Reif B; Haase H; Morano I; Grossmann S; Klukovits A; Verli J; Gáspár R; Noack C; Bergmann M; Kass R; Hampel K; Kashin D; Genieser HG; Herberg FW; Willoughby D; Cooper DM; Baillie GS; Houslay MD; von Kries JP; Zimmermann B; Rosenthal W; Klussmann E
J Biol Chem; 2011 Mar; 286(11):9079-96. PubMed ID: 21177871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
